All In MedTech

Device Trial Radar · NCT06203756

Patient Outcomes With Robotic-Assisted Total Knee Arthroplasty

Improved Patient Outcomes With Robotic-Assisted Total Knee Arthroplasty

Last checked: Nov 19, 2026Latest source record: May 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

713

Planned (sponsor's estimate)

Start

Nov 9, 2017

Primary completion

Jan 1, 2029

Study completion Apr 1, 2040

Sponsor

Lead sponsor
CorinNot on our public-company list
Sponsor type
Industry
First posted
Jan 12, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a post-market multicentre study that has been implemented to confirm safety and performance of cemented CR/UC and PS Apex Knee implants in primary or revision Robotic Assisted Total Knee Arthroplasty up to 10-year follow up.

Conditions

  • Arthroplasties, Knee Replacement
  • Revision Arthroplasty

Interventions

  • Omnibotics Robotic-assisted Total Knee Arthroplasty with Apex UCDevice

    Robotic-assisted total knee arthroplasty in femur and tibial first workflows using the BalanceBot to characterize soft tissue balance, and the Apex UltraCongruent (UC) knee implant type

  • Omnibotics Robotic-assisted Total Knee Arthroplasty with Apex PSDevice

    Robotic-assisted total knee arthroplasty with a tibial first workflow using the BalanceBot to characterize soft tissue balance, and the Apex PosteriorStabilized (PS) knee implant type

  • Omnibotics Robotic-assisted Total Knee Arthroplasty with Apex RevisionDevice

    Robotic-assisted total knee arthroplasty with a tibial first workflow using the BalanceBot to characterize soft tissue balance, and the Apex Revision knee implant type

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SurvivorshipTime frame: 10 Years

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Flagstaff Bone and Joint

    Flagstaff, Arizona

  • Orthopaedics New England

    Middlebury, Connecticut

  • DeClaire LaMacchia Orthopaedic Institute

    Rochester, Michigan

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.